Cite
Hepatitis B treatment eligibility in West Africa: Uncertainties and need for prospective cohort studies
MLA
Judicaël Tine, et al. “Hepatitis B Treatment Eligibility in West Africa: Uncertainties and Need for Prospective Cohort Studies.” Liver International : Official Journal of the International Association for the Study of the Liver, vol. 37, no. 8, Mar. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....dcc0abddcce7ca48247ffbefdba9ef5e&authtype=sso&custid=ns315887.
APA
Judicaël Tine, Marcellin Nouaman, Camille Anoma, François Dabis, Gilles Wandeler, Alain Attia, Didier K. Ekouevi, Antoine Jaquet, André Inwoley, Aristophane Tanon, & Moussa Seydi. (2017). Hepatitis B treatment eligibility in West Africa: Uncertainties and need for prospective cohort studies. Liver International : Official Journal of the International Association for the Study of the Liver, 37(8).
Chicago
Judicaël Tine, Marcellin Nouaman, Camille Anoma, François Dabis, Gilles Wandeler, Alain Attia, Didier K. Ekouevi, et al. 2017. “Hepatitis B Treatment Eligibility in West Africa: Uncertainties and Need for Prospective Cohort Studies.” Liver International : Official Journal of the International Association for the Study of the Liver 37 (8). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....dcc0abddcce7ca48247ffbefdba9ef5e&authtype=sso&custid=ns315887.